{"id":2984,"date":[],"date_gmt":"2024-03-26T17:17:44","guid":{"rendered":"https:\/\/hcp.biomarin.com\/en-gb\/achondroplasia\/?post_type=resource&p=2984"},"modified":"2024-04-08T09:19:14","modified_gmt":"2024-04-08T09:19:14","slug":"c-type-natriuretic-peptide-analogue-therapy-in-children-with-achondroplasia","status":"publish","type":"resource","link":"https:\/\/hcp.biomarin.com\/en-gb\/achondroplasia\/expert\/resource\/c-type-natriuretic-peptide-analogue-therapy-in-children-with-achondroplasia\/","title":{"rendered":"C-Type Natriuretic Peptide Analogue Therapy in Children with Achondroplasia"},"content":{"rendered":"","protected":false},"author":4,"template":"","format":[30],"topic":[50,29,44],"key_opinion_leader":[],"audience":[],"disease_state":[],"region":[],"product":[],"acf":[],"yoast_head":"\n